HBV treatment: the hazy endpoint.
Acharya
S K
SK
D000998:Antiviral Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000097:blood / Q000187:drug effects; D006515:Hepatitis B virus / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D013997:Time Factors
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens